Paper · 42428113
Consensus Recommendations for the Clinical Management of Wolfram syndrome Using a Delphi Method.
Elliott J and 8 others. medRxiv, 2026. Cited by 1 paper, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Consensus Recommendations for the Clinical Management of Wolfram syndrome Using a Delphi Method. Papers, record 42428113. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42428113
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Consensus Recommendations for the Clinical Management of Wolfram syndrome Using a Delphi Method.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 DK132090 | NIDDK NIH HHS | United States | R01DK132090 | PubMed | NIH RePORTER |
| P60 DK020579 | NIDDK NIH HHS | United States | P60DK020579 | PubMed | NIH RePORTER |
| P30 DK020579 | NIDDK NIH HHS | United States | P30DK020579 | PubMed | NIH RePORTER |
| P50 HD103525 | NICHD NIH HHS | United States | P50HD103525 | PubMed | NIH RePORTER |
| UL1 TR002345 | NCATS NIH HHS | United States | UL1TR002345 | PubMed | NIH RePORTER |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References93
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27,395,765 | WFS1 in Optic Neuropathies: Mutation Findings in Nonsyndromic Optic Atrophy and Assessment of Clinical Severity. | Ophthalmology | 2016 | https://conductscience.org/library/papers/27395765 | PubMed |
| 2 | 20,875,904 | Primary diagnosis of Wolfram syndrome in an adult patient--case report and description of a novel pathogenic mutation. | J Neurol Sci | 2011 | https://conductscience.org/library/papers/20875904 | PubMed |
| 3 | 34,831,749 | Urinary Tract Involvement in Wolfram Syndrome: A Narrative Review. | Int J Environ Res Public Health | 2021 | https://conductscience.org/library/papers/34831749 | PubMed |
| 4 | 42,001,184 | Natural history of 15 patients with autosomal dominant WFS1 pathogenic variants associated with sensorineural hearing loss and optic atrophy. | Orphanet J Rare Dis | 2026 | https://conductscience.org/library/papers/42001184 | PubMed |
| 5 | 36,995,380 | GLP-1R agonists demonstrate potential to treat Wolfram syndrome in human preclinical models. | Diabetologia | 2023 | https://conductscience.org/library/papers/36995380 | PubMed |
| 6 | 36,835,101 | Wolfram Syndrome 1: A Pediatrician's and Pediatric Endocrinologist's Perspective. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36835101 | PubMed |
| 7 | 31,796,109 | Developmental hypomyelination in Wolfram syndrome: new insights from neuroimaging and gene expression analyses. | Orphanet J Rare Dis | 2019 | https://conductscience.org/library/papers/31796109 | PubMed |
| 8 | 42,324,630 | Wolfram syndrome and diabetes mellitus in Aotearoa, New Zealand: Phenotype and response to GLP-1 receptor agonist therapy. | Diabet Med | 2026 | https://conductscience.org/library/papers/42324630 | PubMed |
| 9 | 40,010,822 | Sodium valproate, a potential repurposed treatment for the neurodegeneration in Wolfram syndrome (TREATWOLFRAM): trial protocol for a pivotal multicentre, randomised double-blind controlled trial. | BMJ Open | 2025 | https://conductscience.org/library/papers/40010822 | PubMed |
| 10 | 41,870,390 | Optic Atrophy in Wolfram Syndrome Type 1: A Retrospective Analysis of Visual Outcomes and Biomarker Correlates. | J Neuroophthalmol | 2026 | https://conductscience.org/library/papers/41870390 | PubMed |
1 to 10 of 93
See all 93 referencesCited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42,597,412 | Evaluating the use of GLP-1 receptor agonists in Wolfram syndrome patients. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42597412 |
Source PubMed
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CISD2 | 493,856 | PubTator's text mining | https://conductscience.org/library/genes/493856 | NCBI Gene |
| WFS1 | 7,466 | PubTator's text mining | https://conductscience.org/library/genes/7466 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42428113
GET https://conductscience.org/api/papers/v1/42428113/references?page=2